186 related articles for article (PubMed ID: 37760973)
1. Unlocking the Molecular Secrets of Antifolate Drug Resistance: A Multi-Omics Investigation of the NCI-60 Cell Line Panel.
Rushing BR
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760973
[TBL] [Abstract][Full Text] [Related]
2. Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents.
Rushing BR
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686047
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Anticancer antifolates: current status and future directions.
McGuire JJ
Curr Pharm Des; 2003; 9(31):2593-613. PubMed ID: 14529544
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing mice.
Macioszek S; Dudzik D; Bartoszewski R; Stokowy T; Lambrechts D; Boeckx B; Wozniak A; Schöffski P; Markuszewski MJ
Transl Oncol; 2023 Apr; 30():101632. PubMed ID: 36774883
[TBL] [Abstract][Full Text] [Related]
6. Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy.
Yuan Q; Deng D; Pan C; Ren J; Wei T; Wu Z; Zhang B; Li S; Yin P; Shang D
Front Immunol; 2022; 13():951137. PubMed ID: 35990657
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach.
Soares NC; Ali A; Srinivasulu V; Sharaf BM; Giddey AD; Okendo J; Al-Hroub HM; Semreen MH; Hamad M; Al-Tel TH
J Proteomics; 2022 Aug; 265():104660. PubMed ID: 35728772
[TBL] [Abstract][Full Text] [Related]
8. Multi-Omics Analysis Revealed a Significant Alteration of Critical Metabolic Pathways Due to Sorafenib-Resistance in Hep3B Cell Lines.
Abushawish KYI; Soliman SSM; Giddey AD; Al-Hroub HM; Mousa M; Alzoubi KH; El-Huneidi W; Abu-Gharbieh E; Omar HA; Elgendy SM; Bustanji Y; Soares NC; Semreen MH
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233276
[TBL] [Abstract][Full Text] [Related]
9. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Signature of Articular Cartilage Following Mechanical Injury: An Integrated Transcriptomics and Metabolomics Analysis.
Southan J; McHugh E; Walker H; Ismail HM
Front Mol Biosci; 2020; 7():592905. PubMed ID: 33392255
[TBL] [Abstract][Full Text] [Related]
11. Advances in Multi-Omics Approaches for Molecular Breeding of Black Rot Resistance in
Shaw RK; Shen Y; Wang J; Sheng X; Zhao Z; Yu H; Gu H
Front Plant Sci; 2021; 12():742553. PubMed ID: 34938304
[No Abstract] [Full Text] [Related]
12. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells.
Sato Y; Matsuda S; Maruyama A; Nakayama J; Miyashita T; Udagawa H; Umemura S; Yanagihara K; Ochiai A; Tomita M; Soga T; Tsuchihara K; Makinoshima H
Front Pharmacol; 2018; 9():1129. PubMed ID: 30369878
[TBL] [Abstract][Full Text] [Related]
14. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of antifolate resistance.
Assaraf YG
Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
[TBL] [Abstract][Full Text] [Related]
16. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
[No Abstract] [Full Text] [Related]
17. Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.
Xu Y; Dong Q; Li F; Xu Y; Hu C; Wang J; Shang D; Zheng X; Yang H; Zhang C; Shao M; Meng M; Xiong Z; Li X; Zhang Y
J Transl Med; 2019 Aug; 17(1):255. PubMed ID: 31387579
[TBL] [Abstract][Full Text] [Related]
18. Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer.
Li X; Du Y; Jiang W; Dong S; Li W; Tang H; Yi J; Zhou W; Zhang H
Front Immunol; 2023; 14():1170223. PubMed ID: 37662928
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates.
Sierra EE; Goldman ID
Semin Oncol; 1999 Apr; 26(2 Suppl 6):11-23. PubMed ID: 10598550
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
